Gothamist
A non-profit newsroom, powered by WNYC.
Gothamist
Listen Live
News
Magic Mushrooms May Hold Cure For The Mondays
By
Christopher Robbins
Published Jan 23, 2012
Modified Jan 23, 2012
Share
FacebookTwitterRedditEmail
Never miss a story
Email address
By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .
By
Christopher Robbins
Published Jan 23, 2012
Modified Jan 23, 2012
Share
FacebookTwitterRedditEmail
We rely on your support to make local news available to all
Make your contribution now and help Gothamist thrive in 2026. Donate today
Gothamist is funded by sponsors and member donations
Psychotropic drugs: what can't they do? Two different medical studies show that psilocybin, the active drug found in magic mushrooms, may assist in treating depression. In a study published in the Proceedings of the National Academy of Sciences, after 30 volunteers took intravenous doses of psilocybin, MRI readings showed that the portion of the brain most active in depression was lowered. Another study to be published in the British Journal of Psychiatry showed that the chemical intensified positive memories.
Robin Carhart-Harris, a co-author of the first study, released a statement quoted by Bloomberg in which she suggests that "used in combination with psychotherapy, psilocybin might help people recall positive life events and reverse pessimistic mindsets.” Rather than being hooked on Prozac for a lifetime, psilocybin could provide an "enduring benefit" after just a single dose.
Psilocybin's positive uses have been noted long before Timothy Leary founded the Harvard Psilocybin Project, as hallucinogenic mushrooms have been used therapeutically for hundreds of years. Naturally, the United States classifies them as a schedule I drug, meaning the have"a high potential for abuse" and "no legitimate medical purpose." Except when you're trying to make a Portlandia PR party bearable.
Tagged
depression
drugs
hallucinogens
magic mushrooms
psilocybin
war on drugs
Christopher Robbins
Christopher Robbins is a New York City reporter covering transportation, affordable housing, local politics, and criminal justice. His work has also appeared in New York Magazine, The Village Voice and The New York Times. Chris is a graduate of Patrick Henry High School in Roanoke, Virginia, and enjoys biking to Fort Tilden in the summertime.
Read more
Gothamist is funded by sponsors and member donations
Gothamist is funded by sponsors and member donations
MORE news
NYPD arrests and charges city schools employee in murder of Brooklyn jogger
The NYPD said it has charged Sayed Mohassib with murder.
By
Kaya Laterman
Published Nov 7, 2026 at 1:39 p.m. ET
Modified Nov 7, 2026 at 2:07 p.m. ET
Work is underway to replace deteriorating Newark Bay Bridge, a major NY-NJ route
The new bridge should be ready in 2031, with minimal disruption to commuters while it's being built, officials say.
By
Michael Sol Warren
News
Work is underway to replace deteriorating Newark Bay Bridge, a major NY-NJ route
The new bridge should be ready in 2031, with minimal disruption to commuters while it's being built, officials say.
By
Michael Sol Warren
Quest Diagnostics pays $13M to settle kickback allegations involving NY Giants tickets
By
Kaya Laterman
Person found dead with stab wounds in Queens building, NYPD says
By
Giulia Heyward
Amtrak's Penn Station plan could funnel taxpayer money to new venue for James Dolan
By
Ramsey Khalifeh
Never miss a story
Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.
Sign upEmail address
By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .